SCHEMBL21035104

SCHEMBL21035104

CC(C)(C)OC(=O)NC1CCN(C(=O)[C@@H]2CN(Cc3ccc(-c4ccc(Cl)cc4)cc3)CCN2S(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.42
MMP9 P14780 4/20 0.42
MMP13 P45452 3/20 0.42
MMP3 P08254 2/20 0.42
MMP7 P09237 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CCR2 P41597 3/20 0.41
DRD4 P21917 2/20 0.41
HTR2A P28223 2/20 0.41
EPHX2 P34913 3/20 0.40
CHRM4 P08173 1/20 0.40
PRKAA2 P54646 2/20 0.39
ACHE P22303 1/20 0.39
EPHX1 P07099 1/20 0.39
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035474 1.00 MMP1 (0.42) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035608 1.00 MMP1 (0.42) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035503 0.90 EPHX2 (0.39) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035600 0.88 MEN1 (0.41) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035442 0.88 MEN1 (0.41) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035340 0.88 MEN1 (0.41) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035480 0.86 GHSR (0.46) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035105 0.86 GHSR (0.46) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035611 0.86 GHSR (0.46) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035072 0.85 CCR4 (0.42) MMP1MMP9MMP13MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed